Promising New Drug Could Slow Progression of ALS
John Jeffay via Israel21c – A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup developing a drug combo that aims to slow progression…
Potential ALS Drug Gets Boost Toward Preclinical Trials
Abigail Klein Leichman via Israel21c – A new class of small molecules for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, and other neurodegenerative diseases, is being developed at…
URI Engineering Professor Helping ALS Patients Use Their Brains to Communicate
University of Rhode Island via Newswise – Doug Sawyer was diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, 11 years ago. His only muscles that still…
